VDM-11

VDM-11 is a drug that acts as a selective antagonist for the cannabinoid receptor CB1. It has been used in scientific research to explore the role of the CB1 receptor in the regulation of neurotransmission, and the potential therapeutic applications of CB1 antagonists. VDM-11 does not cross the blood-brain barrier, so its effects are peripheral only.

Pharmacology

VDM-11 acts as a selective antagonist at the CB1 receptor, which is one of the two main types of cannabinoid receptors in the body. The CB1 receptor is primarily found in the brain, but is also present in other tissues. VDM-11 does not cross the blood-brain barrier, so it does not have any central effects.

Research Uses

VDM-11 has been used in scientific research to investigate the role of the CB1 receptor in the regulation of neurotransmission. It has also been used to explore the potential therapeutic applications of CB1 antagonists, particularly in the treatment of obesity and metabolic disorders.

See Also

• Cannabinoid receptor
• CB1 receptor
• Cannabinoid receptor antagonist

References

VDM-11 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski